Dyspepsia: all 370 studies
Page 4 of 4. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus ReuteriStatus unknownNCT01028690Not applicable
- Does Visceral Manipulation Works in Treating Functional Dyspepsia?Status unknownNCT01021475Phase 1
- Mucosal Barrier Defects in Functional Dyspepsia by Confocal Laser EndomicroscopyStatus unknownNCT01006642
- Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic GastritisCompletedNCT00996788Phase 3
- Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional DyspepsiaStatus unknownNCT00990405Phase 4
- Efficacy of Banhasasim-tang on Functional DyspepsiaCompletedNCT00987805Phase 4
- Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer DyspepsiaStatus unknownNCT00978159Phase 4
- Does Small Intestinal Bacterial Overgrowth Contribute to Functional DyspepsiaCompletedNCT00956397Not applicable
- Gastric Functions & Proton Pump Inhibitor( PPI) StudyCompletedNCT00951431Phase 4
- Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal TractCompletedNCT00920400
- A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy AdultsCompletedNCT00850746Phase 1
- Treatment of Functional Dyspepsia With AcupunctureCompletedNCT00786214Not applicable
- Effect of Eradication of Helicobacter Pylori on the Dyspeptic SymptomsCompletedNCT00772837Not applicable
- A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional DyspepsiaCompletedNCT00764374Phase 3
- To Verify the Efficacy of Z-338 in Subjects With Functional DyspepsiaCompletedNCT00761358Phase 3
- Domperidone for Relief of Gastrointestinal DisordersTerminatedNCT00761254Not applicable
- Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected PatientsCompletedNCT00723502Phase 2
- Study of Endogenous Inhibitory Modulation During Gastric and Somatic StimulationCompletedNCT00693407Not applicable
- Comparative Study of Epigastric Pain Syndrome and Postprandial Distress SyndromeWithdrawnNCT00673972Phase 4
- The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal MetaplasiaStatus unknownNCT00673699
- Lansoprazole Versus Mosapride for Functional DyspepsiaCompletedNCT00663897Phase 4
- Randomized Controlled Trial of Acupuncture for Functional DyspepsiaCompletedNCT00599677Not applicable
- Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in ChildrenCompletedNCT00521703Phase 3
- The Effect of Z-338 in Subjects With Functional DyspepsiaCompletedNCT00458328Phase 2
- Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory DrugsWithdrawnNCT00443963Phase 4
- Functional Dyspepsia - Effect of Acid-Reducing Treatment and Information.TerminatedNCT00437346Not applicable
- Helicobacter Eradication Relief of Dyspeptic SymptomsCompletedNCT00404534Phase 3
- Study of Long-Term Use of Proton-Pump-Inhibitors in General PracticeStatus unknownNCT00363701Phase 4
- Intestinal Permeability in Children/Adolescents With Functional DyspepsiaCompletedNCT00363597
- An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional DyspepsiaCompletedNCT00358410Phase 2
- To Evaluate the Efficacy of Z-338 in Subjects With Functional DyspepsiaCompletedNCT00333372Phase 2
- Evaluation of Food Hypersensitivity in Children/Adolescents With Functional DyspepsiaCompletedNCT00328679Phase 1
- To Evaluate the Efficacy and Safety in Subjects With Functional DyspepsiaCompletedNCT00323817Phase 2
- The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.CompletedNCT00303264Phase 2
- The Effects of Z-338 in Subjects With and Without Functional DyspepsiaCompletedNCT00298194Phase 2
- Gastric Motor Function Measurement in Dyspepsia and Normal SubjectsCompletedNCT00296582Not applicable
- NAET® Testing Devices in Detection of Hypersensitivity to Cane SugarCompletedNCT00292578Phase 1/2
- Antibiotic Resistant Helicobacter Pylori in Rajavithi HospitalCompletedNCT00285688
- The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and DyspepsiaWithdrawnNCT00277550Phase 4
- Activation and Recruitment of GIL During Hp InfectionStatus unknownNCT00275886
- NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®CompletedNCT00275795
- Use of MRI for Assessing Stomach Relaxation in Response to a MealCompletedNCT00275743Phase 1
- Itopride in Functional Dyspepsia:a Dose Finding StudyCompletedNCT00272103Phase 2/3
- Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux DiseaseActive, not recruitingNCT00260572
- Nexium Dyspepsia/ASTCompletedNCT00251992Phase 3
- Nexium Dyspepsia/ASTCompletedNCT00251914Phase 3
- Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)CompletedNCT00247715Not applicable
- HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCompletedNCT00243724Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232102Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232089Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232037Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232024Phase 3
- Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic PatientsCompletedNCT00220883
- Tricyclic Antidepressants (TCAs) on Gastric EmptyingTerminatedNCT00220844Not applicable
- Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper EndoscopyCompletedNCT00217347Not applicable
- Lymphocytic Subsets and Cytokine Production With H. Pylori InfectionCompletedNCT00173953Not applicable
- The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.CompletedNCT00171470Phase 3
- The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.CompletedNCT00171457Phase 3
- Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patient With or Without Local Pharyngeal AnaesthesiaCompletedNCT00164996Phase 3
- The Efficacy of Imipramine in Treatment of Refractory Functional DyspepsiaCompletedNCT00164775Phase 3
- Montelukast in the Treatment of Duodenal EosinophiliaCompletedNCT00148603Not applicable
- Helicobacter Pylori Eradication With a New Sequential TreatmentCompletedNCT00132171Phase 3
- Proton Pump Inhibitor Treatment StopCompletedNCT00120315Phase 4
- Serotonin Effect in Functional DyspepsiaCompletedNCT00115362Not applicable
- Defining Central Circuits of PainCompletedNCT00112333Not applicable
- Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaCompletedNCT00112203Phase 3
- Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a MealCompletedNCT00112190Phase 3
- Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a MealCompletedNCT00112177Phase 3
- Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaCompletedNCT00110968Phase 3
- YM443 in Subjects With Functional DyspepsiaCompletedNCT00102310Phase 2